ADVERTISEMENT

Rossari Biotech Q1 Results Review - Steady Performance: ICICI Securities

The brokerage keeps its EPS estimates unchanged, but increase target price to Rs 885, maintains Add.

<div class="paragraphs"><p>Technician at Rossari Biotech R&amp;D lab. (Soruce: Company website)</p></div>
Technician at Rossari Biotech R&D lab. (Soruce: Company website)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More